Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

India: Emerging Hub of Pharmaceutical R&D

Posted on November 7th, 2016 by in Pharma R&D

For many of the last five decades, India has been known as the largest exporter of generic drugs, particularly to the United States. However, today, in 2016, India is getting to be known for a bit more than that: (more…)

R&D Innovation & Pharma Drug-Device Pricing

Posted on September 26th, 2016 by in Pharma R&D

The media as of late has given a lot of coverage to the “price gouging” that pharmaceutical company Mylan engaged in with its injection device EpiPen. (more…)

Elsevier and Illumina: A meeting of mind and spirit

Posted on August 22nd, 2016 by in Pharma R&D

One of the strongest arguments for using the molecular biology modeling tool Pathway Studio is the rich content underlying its knowledge database. This was driven home recently in a conversation with the DNA/RNA sequencing company Illumina. (more…)

Predictions, Modelling and Simulations: Their role in R&D decision-making is more “what” than “how”?

Posted on August 8th, 2016 by in Pharma R&D

R_D_Solutions_Blog_Data_Center_DIGITAL

“Predictions are difficult, especially when they are about the future”, a statement attributed to the Noble laurate Niels Bohr is very true.  Despite these difficulties, the Pharma industry has built a range of predictive models to understand a range of drug actions including toxicity, disposition, elimination and efficacy.  (more…)

  1. 1
  2. 4
  3. 5
  4. 6
  5. 7